| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |